Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $190 from $181 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target raised to $182 from $162 at Argus
- Cardinal Health’s Strong Growth Prospects and Enhanced Shareholder Value Drive Buy Rating
- Cardinal Health price target raised to $180 from $170 at BofA
- Cardinal Health price target raised to $181 from $166 at Morgan Stanley
- Cardinal Health price target raised to $170 from $157 at Citi